100 Recruiting Studies Using Prednisone
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Prednisone
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
📍 The University of Arizona Cancer Center - North Campus /ID# 242219 — Tucson, Arizona
Non-Hodgkin Lymphoma
View Study & Checklist ➔A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
📍 Urology Centers Of Alabama — Homewood, Alabama
Castration-Resistant Prostatic Cancer
View Study & Checklist ➔A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Prostate Cancer
View Study & Checklist ➔Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients
📍 MorphoSys Research Site — Daphne, Alabama
Diffuse Large B-cell Lymphoma
View Study & Checklist ➔Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
📍 Yale Cancer Center — New Haven, Connecticut
Stage II Prostate Adenocarcinoma
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
📍 University of Arizona Cancer Center - North Campus /ID# 227463 — Tucson, Arizona
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Stage II Childhood Hodgkin Lymphoma
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
Castration-Sensitive Prostate Carcinoma
View Study & Checklist ➔Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
📍 Research Site — Tucson, Arizona
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Non Hodgkin Lymphoma (NHL)
View Study & Checklist ➔A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
📍 Urological Associates of Southern Arizona, P.C. — Tucson, Arizona
Prostatic Neoplasms, Castration-Resistant
View Study & Checklist ➔A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 Clinical Research Facility — Los Angeles, California
Prostatic Neoplasms
View Study & Checklist ➔Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D
📍 Casey Eye Institute - Oregon Health & Science University — Portland, Oregon
Leber Congenital Amaurosis
View Study & Checklist ➔A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
📍 James P. Wilmot Cancer Institute, University of Rochester Medical Center — Rochester, New York
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma
📍 Cleveland Clinic — Cleveland, Ohio
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)
📍 The Hospital for Sick Children — Toronto, Ontario
Nephrotic Syndrome in Children
View Study & Checklist ➔Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE)
📍 UCSF Benioff Children's Hospital, 747 52nd St — Oakland, California
Gaucher Disease, Type 2
View Study & Checklist ➔Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Prostate Adenocarcinoma
View Study & Checklist ➔Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Melanoma Stage III
View Study & Checklist ➔Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)
📍 Children's Hospital of Alabama ( Site 0023) — Birmingham, Alabama
Hodgkin Lymphoma
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
📍 Local Institution - 0152 — Birmingham, Alabama
Lymphoma, Follicular
View Study & Checklist ➔A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
📍 Urology Centers Of Alabama — Homewood, Alabama
Metastatic Castration-sensitive Prostate Cancer
View Study & Checklist ➔Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist ➔Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
📍 Alaska Breast Care and Surgery LLC — Anchorage, Alaska
Grade 1 Follicular Lymphoma
View Study & Checklist ➔Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
📍 H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida
Prostate Cancer
View Study & Checklist ➔Study of Axicabtagene Ciloleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Follicular Lymphoma
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Relapsed/Refractory Follicular Lymphoma
View Study & Checklist ➔An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)
📍 Clinical Research Facility — Phoenix, Arizona
Prostatic Neoplasms
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
📍 Lucile Packard Children's Hospital - Stanford — Palo Alto, California
Childhood Idiopathic Nephrotic Syndrome
View Study & Checklist ➔A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
📍 University of Rochester — Rochester, New York
DLBCL
View Study & Checklist ➔Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorders
View Study & Checklist ➔Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
📍 University of California Los Angeles — Los Angeles, California
Prostate Cancer Metastatic Castration-Resistant
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
Metastatic Prostate Carcinoma
View Study & Checklist ➔Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
📍 University of Alabama Hospital — Birmingham, Alabama
High-risk Large B-cell Lymphoma (LBCL)
View Study & Checklist ➔Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
📍 Arizona Oncology Associates, P.C. - HOPE — Prescott, Arizona
Prostatic Neoplasms
View Study & Checklist ➔Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Metastatic Prostate Cancer
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
📍 Providence Hospital — Mobile, Alabama
Ann Arbor Stage II Non-Hodgkin Lymphoma
View Study & Checklist ➔Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC
📍 Exelixis Clinical Site #4 — Tucson, Arizona
Metastatic Prostate Cancer
View Study & Checklist ➔M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)
📍 NEXT Oncology - PARENT — New York, New York
Advanced Solid Tumor
View Study & Checklist ➔An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
📍 Alaska Oncology & Hematology, LLC — Anchorage, Alaska
Large B-Cell Lymphoma
View Study & Checklist ➔Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
📍 University of Texas Southwestern — Dallas, Texas
B-cell Lymphoma
View Study & Checklist ➔Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
📍 M D Anderson Cancer Center — Houston, Texas
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritis
📍 University of Alabama at Birmingham Medical Center — Birmingham, Alabama
Lupus Nephritis
View Study & Checklist ➔Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoma
View Study & Checklist ➔Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Aggressive Non-Hodgkin Lymphoma
View Study & Checklist ➔A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
📍 START Mountain Region — West Valley City, Utah
Prostatic Neoplasms
View Study & Checklist ➔ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer
📍 UC San Diego Moores Cancer Center — La Jolla, California
Metastatic Prostate Cancer
View Study & Checklist ➔Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
📍 Providence Hospital — Mobile, Alabama
Multiple Myeloma
View Study & Checklist ➔Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
📍 UCSF Fresno /ID# 264712 — Fresno, California
Follicular Lymphoma (FL)
View Study & Checklist ➔A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
📍 Boca Raton Clinical Research (BRCR) Global — Plantation, Florida
Follicular Lymphoma (FL)
View Study & Checklist ➔A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
📍 Site US10052 — Anchorage, Alaska
Prostate Cancer
View Study & Checklist ➔Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Castration Levels of Testosterone
View Study & Checklist ➔Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
Prostate Cancer
View Study & Checklist ➔LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
📍 Children's of Alabama — Birmingham, Alabama
Langerhans Cell Histiocytosis
View Study & Checklist ➔Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Primary Mediastinal Large B-Cell Lymphoma
View Study & Checklist ➔Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma
📍 University of Chicago — Chicago, Illinois
Prostate Cancer
View Study & Checklist ➔Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
📍 Colorado Blood Cancer Institute — Denver, Colorado
Autoimmune Disease
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Lymphoma
View Study & Checklist ➔Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
📍 City of Hope Comprehensive Cancer Center — Los Angeles, California
Castration-Resistant Prostatic Cancer
View Study & Checklist ➔Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma
📍 Local Institution - 0014 — Mobile, Alabama
Large B-cell Lymphoma
View Study & Checklist ➔Tailored Prednisone Reduction in Preventing Hyperglycemia in Participants With B-Cell Non-Hodgkin Lymphoma Receiving Combination Chemotherapy Treatment
📍 Wake Forest University Health Sciences — Winston-Salem, North Carolina
B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma
📍 Karmanos Cancer Institute — Detroit, Michigan
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Adult T-Cell Leukemia/Lymphoma
View Study & Checklist ➔Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Effusion Lymphoma
View Study & Checklist ➔Split-Dose R-CHOP for Older Adults With DLBCL
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Diffuse Large B Cell Lymphoma
View Study & Checklist ➔Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (VIPOR) for Diffuse Large B-cell Lymphoma Involving the Central Nervous System
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Diffuse Large B-cell Lymphoma of the Central Nervous System (CNS)
View Study & Checklist ➔A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham — Birmingham, Alabama
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
View Study & Checklist ➔Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Ann Arbor Stage IIB Hodgkin Lymphoma
View Study & Checklist ➔Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Castration Levels of Testosterone
View Study & Checklist ➔Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
📍 OHSU Knight Cancer Institute — Portland, Oregon
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma
📍 Local Institution - 162 — Birmingham, Alabama
Lymphoma, B-Cell
View Study & Checklist ➔A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.
📍 University of Arkansas for Medical Sciences-Site Number : 8400019 — Little Rock, Arkansas
Chronic Graft Versus Host Disease
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Hodgkin Lymphoma
View Study & Checklist ➔Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
📍 NCI Lymphoid Malignancies Branch — Bethesda, Maryland
AIDS-Related Burkitt Lymphoma
View Study & Checklist ➔Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
📍 UC San Diego Moores Cancer Center — La Jolla, California
AIDS-Related Lymphoma
View Study & Checklist ➔Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Prostate Carcinoma
View Study & Checklist ➔Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
📍 Moffitt Cancer Center - McKinley Campus — Tampa, Florida
Clinical Stage III Cutaneous Melanoma AJCC v8
View Study & Checklist ➔Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell Lymphoma
📍 Mount Sinai Hospital — New York, New York
Mantle Cell Lymphoma
View Study & Checklist ➔A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Lymphoproliferative Disorder
View Study & Checklist ➔A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)
📍 BC Cancer Victoria-Clinical Trials Unit ( Site 0105) — Victoria, British Columbia
Lymphoma, Large B-Cell, Diffuse (DLBCL)
View Study & Checklist ➔Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
📍 Washington University School of Medicine — St Louis, Missouri
Kidney Transplant Recipient
View Study & Checklist ➔Infliximab for Immune Checkpoint Inhibitor Associated AKI
📍 Massachusetts General Hospital — Boston, Massachusetts
Acute Kidney Injury
View Study & Checklist ➔Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔